Brief Shame Intervention Study

NCT03463356 | Completed

• 1 other identifier: 01474r
• Study Type: interventional
• Target: 14
• Locations: 1 country
• Sites: 1

Brief Summary

The current project will develop and test a brief 2-session shame intervention in individuals diagnosed with social anxiety disorder (SAD). Using a non-concurrent multiple baseline design, the investigators will determine whether the brief shame intervention leads to reductions in trait self-reported shame and state shame in response to an in vivo stressor task. The investigators will also evaluate the effect of changes in shame on trait SAD symptoms.

Conditions

Shame; Social Anxiety Disorder

Outcome Measures

Primary Outcomes (1)

• Change in Test of Self-Conscious Affect-3-Short Form

  Self-report of how likely an individual is to react to 11 scenarios with shame responses

  Participants indicate likelihood of responses to scenarios. Administered at B1-B5 and T1-T5. B1-B5 occur ~1 week apart. T1 occurs ~1 week after the final baseline. T1-T4 each occur within ~2 weeks of each other. T5 occuring ~1 month after T4.

Secondary Outcomes (4)

• Change in Liebowitz Social Anxiety-Self-Report

  Participants report on symptoms during the past week. Administered at T1-T5. T1-T4 each occur within ~2 weeks of each other. T5 occurs ~1 month after T4.

• Change in Brief State Anxiety Measure

  Participants report on symptoms experienced during the speech task. Administered at T1 and T4. T4 occurs within ~6 weeks after T1.

• Change in Shame Inventory

  Participants report on typical experience of symptoms. Administered at T1, T4, and T5. T4 occurs within ~6 weeks after T1. T5 occurs ~1 month after T4.

• Change in State Shame and Guilt Measure

  Participants report on symptoms experienced during the speech task. Administered at T1 and T4. T4 occurs within ~6 weeks after T1.

Other Outcomes (5)

• Change in Center for Epidemiologic Studies Depression Measure

  Participants report on symptoms experienced during the past week. Administered at T1, T4, and T5. T4 occurs within ~6 weeks after T1. T5 occurs ~1 month after T4.

• Change in Clinical Perfectionism Measure

  Participants report on symptoms experienced during the past month. Administered at T1, T4, and T5. T4 occurs within ~6 weeks after T1. T5 occurs ~1 month after T4.

• Change in Eating Disorder Inventory - 3rd Version

  Participants report on typical experience of symptoms. Administered at T1, T4, and T5. T4 occurs within ~6 weeks after T1. T5 occurs ~1 month after T4.

Study Arms (1)

Shame Intervention

EXPERIMENTAL

Participants will complete a two shame intervention sessions approximately one week apart.

Behavioral: Shame Intervention

Interventions

Shame Intervention BEHAVIORAL

In the Shame Intervention, participants will meet with a therapist and learn to: 1) Recognize the experience of shame, 2) Understand the connection between shame and social anxiety, 3) Identify shame triggers and vulnerabilities, 4) Identify the thoughts and behaviors that keep participants stuck in shame, and 5) Learn how to use new, healthier thoughts and behaviors that will help participants move through and decrease shame.

Shame Intervention

Eligibility Criteria

• Age: 18 Years - 100 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• ≥ 18 years old
• fluent in English, in terms of verbal and written competence
• meet diagnostic criteria for social anxiety disorder (as assessed by the Diagnostic Interview for Anxiety, Mood, and OCD and Related Neuropsychiatric Disorders; Tolin et al., 2016)
• have elevated levels of shame (i.e., score 1 SD above the Test of Self-Conscious Affect-3 \[TOSCA-3\] means reported by an unselected undergraduate sample \[M = 33.62, SD = 8.64\])
• endorse a desire to decrease their levels of shame and/or social anxiety.

You may not qualify if:

• currently receiving cognitive-behavioral therapy specifically for social anxiety or shame
• have begun taking or had a change in dosage of psychotropic medication in the past six weeks
• do not achieve baseline stability

Sponsors & Collaborators

• Miami University: lead

Study Sites (1)

Anxiety Cognition and Emotion Laboratory

Oxford, Ohio, 45212, United States

Location

MeSH Terms

Conditions

Phobia, Social

Condition Hierarchy (Ancestors)

Phobic Disorders; Anxiety Disorders; Mental Disorders

Study Officials

• Marie Parsons, M.A.

  Miami University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Professor

Model Details: non-concurrent multiple baseline design

Study Record Dates

• First Submitted: March 1, 2018
• First Posted: March 13, 2018
• Study Start: February 15, 2018
• Primary Completion: June 30, 2018
• Study Completion: June 30, 2018
• Last Updated: February 7, 2019

Record last verified: 2019-02

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)